Successful lifestyle modification in older patients with coronary artery disease: results from the RESPONSE-2 trial

Autor: Madelon Minneboo, R. J. G. Peters, G. ter Riet, Sangeeta Lachman, Marjolein Snaterse, Patricia Jepma, S. M. Boekholdt, Harald T. Jørstad, J.A. Kragten, W.J.M. Scholte op Reimer
Přispěvatelé: Urban Vitality, Kenniscentrum ACHIEVE, Faculteit Gezondheid, Cardiology, ACS - Atherosclerosis & ischemic syndromes, ACS - Heart failure & arrhythmias, Graduate School, Nursing, AMS - Sports, APH - Aging & Later Life, APH - Personalized Medicine, ACS - Diabetes & metabolism, APH - Quality of Care
Rok vydání: 2020
Předmět:
Zdroj: European Society of Cardiology congress
Jepma, P, Jorstad, H T, Snaterse, M, ter Riet, G, Kragten, J A, Lachman, S, Minneboo, M, Boekholdt, S M, Peters, R J G & Scholte op Reimer, W J M 2020, ' Successful lifestyle modification in older patients with coronary artery disease: results from the RESPONSE-2 trial ' .
ISSN: 1522-9645
0195-668X
Popis: Introduction Interventions to reduce lifestyle-related risk factors (LRFs) such as overweight, physical inactivity and smoking are effective in the secondary prevention of cardiovascular events. However, evidence of the effects of lifestyle-related secondary prevention programmes in older patients with coronary artery disease (CAD) is less conclusive than in younger patients. Purpose To compare the treatment effect on lifestyle-related risk factors (LRFs) in older (≥65 years) versus younger ( Methods The RESPONSE-2 trial was a community-based lifestyle intervention trial (N=824) comparing nurse-coordinated referral to a comprehensive set of three lifestyle interventions (physical activity, weight reduction and/or smoking cessation) to care as usual. The primary outcome was the proportion of patients with improvement at 12 months follow-up (N=711) in at least 1 LRF (without deterioration in the other LRFs). In the current analysis, we assessed if the overall beneficial treatment effect of the RESPONSE-2 intervention varied by age. Results At baseline, older patients (n=245, 69.2±3.9) had significantly more serious cardiovascular risk profiles and comorbidities (hypertension, diabetes mellitus and peripheral artery disease) than younger patients (n=579, 53.7±3.9). The overall treatment effect did not vary by age (OR overall 1.67, 95% CI 1.22 - 2.31). However, older patients were more likely to achieve ≥5% weight loss (OR old 5.58, 95% CI 2.77–11.26 vs. OR young 1.57, 95% CI 0.98 - 2.49, P interaction=0.003) and younger patients were more likely to show non-improved individual LRFs (OR old 0.38, 95% CI 0.22–0.67 vs. OR young 0.88, 95% CI 0.61–1.26, P interaction=0.01). Conclusion Despite more serious cardiovascular risk profiles and comorbidities among older patients, nurse-coordinated referral to community-based lifestyle interventions was at least as successful in improving LRFs in older as in younger patients. Higher age alone should not be a reason to withhold lifestyle interventions in patients with CAD. LRFs at 12 months follow-up Funding Acknowledgement Type of funding source: Private company. Main funding source(s): The RESPONSE-2 trial was sponsored by Weight Watchers International, Inc. (New York, New York) and Philips Consumer Lifestyle (the Netherlands). This work was also supported by the Netherlands Organisation for Scientific Research (NWO) to PJ.
Databáze: OpenAIRE
Externí odkaz: